Form 8-K - Current report:
SEC Accession No. 0001193125-19-198589
Filing Date
2019-07-22
Accepted
2019-07-22 08:35:03
Documents
3
Period of Report
2019-07-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d777565d8k.htm 8-K 17667
2 EX-99.1 d777565dex991.htm EX-99.1 9268
3 GRAPHIC g777565g0722114425482.jpg GRAPHIC 4337
  Complete submission text file 0001193125-19-198589.txt   34193
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34186 | Film No.: 19964546
SIC: 2834 Pharmaceutical Preparations